Suppr超能文献

通过喷雾干燥法制备壳聚糖微粒时优化配方因素。

Optimizing formulation factors in preparing chitosan microparticles by spray-drying method.

作者信息

Huang Y-C, Chiang C-H, Yeh M-K

机构信息

Graduate Institute of Life Science, National Defense Medical Center, Taipei, Taiwan.

出版信息

J Microencapsul. 2003 Mar-Apr;20(2):247-60.

Abstract

The chitosan only, chitosan/Pluronic F68, chitosan/gelatin, chitosan/Pluronic F68/gelatin microparticles and betamethasone-loaded chitosan/Pluronic F68/gelatin microparticles were successfully prepared by a spray-drying method. Microparticle characteristics (yield rate, zeta potential, particle size and tap density), loading efficiencies, microparticle morphology and in-vitro release properties were investigated. By properly choosing excipient type, concentration and varying the spray-drying parameters, a high degree of control was achieved over the physical properties of the dry chitosan powders. SEM micrograph shows that the particle sizes of the varied chitosan composed microparticles ranged from 2.12-5.67 microm and the external surfaces appear smooth. Using betamethasone as model drug, the spray-drying is a promising way to produce good spherical and smooth surface microparticles with a narrow particle size range for controlled delivery of betamethasone. The positively charged betamethasone-loaded microparticles entrapped in the chitosan/Pluronic F68/gelatin microparticles with trapping efficiencies up to 94.5%, yield rate 42.5% and mean particle size 5.64 microm varied between 4.32-6.20 microm and tap densities 0.128 g/cm(3). The pH of particle was increased with increasing betamethasone-loaded amount, but both zeta potential and tap density of the particles decreased with increasing betamethasone-loaded amount. The betamethasone release rates from chitosan/Pluronic F68/gelatin microparticles were influenced by the drug/polymer ratio in the manner that an increase in the release% and burst release% was observed when the drug loading was decreased. The in vitro release of betamethasone showed a dose-dependent burst followed by a slower release phase that was proportional to the drug concentration in the concentration range between 14-44%w/w.

摘要

通过喷雾干燥法成功制备了仅壳聚糖、壳聚糖/普朗尼克F68、壳聚糖/明胶、壳聚糖/普朗尼克F68/明胶微球以及载有倍他米松的壳聚糖/普朗尼克F68/明胶微球。研究了微球特性(产率、ζ电位、粒径和振实密度)、载药效率、微球形态及体外释放特性。通过合理选择辅料类型、浓度并改变喷雾干燥参数,实现了对干燥壳聚糖粉末物理性质的高度控制。扫描电子显微镜照片显示,不同壳聚糖组成的微球粒径范围为2.12 - 5.67微米,且外表面光滑。以倍他米松为模型药物,喷雾干燥是制备具有良好球形且表面光滑、粒径范围窄的微球以实现倍他米松控释的一种有前景的方法。载有倍他米松的带正电荷微球包封于壳聚糖/普朗尼克F68/明胶微球中,包封效率高达94.5%,产率42.5%,平均粒径5.64微米,粒径在4.32 - 6.20微米之间变化,振实密度为0.128 g/cm³。随着倍他米松载药量增加,颗粒的pH升高,但颗粒的ζ电位和振实密度均降低。壳聚糖/普朗尼克F68/明胶微球中倍他米松的释放速率受药物/聚合物比例影响,当载药量降低时,释放百分比和突释百分比增加。倍他米松的体外释放呈现剂量依赖性突释,随后是较慢的释放阶段,在14 - 44%w/w的浓度范围内,该阶段与药物浓度成正比。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验